Pinned post
We've recently launched a global survey on the potential use of #TILs for future trial designs and use in daily practice. We would love to hear what you have to say 👇fd7.formdesk.com/BQA/TILs_TNBC_…
TILs Working Group
@TILsWorkGroup
We are interested in the immune infiltrate in Breast cancer and what it means for treatment and prevention.
109 Following 833 Followers 259 Posts
Latest posts 5
open.spotify.com Tumour-infiltrating lymphocytes in breast cancer with Professor Sherene Loi The Lancet Oncology in conversation with · Episode 🆕Our Sept issue is now live!
📊Articles: #hepatocellularcarcinoma #NSCLC #rectalcancer #breastcancer #prostatecancer
📉Featuring trials: EMERALD-3, HARMONi, ALINA, STAR-TREC, & GETUG AFU 18
🎨Cover: breast cancer, TILs, and AI
🖱️Read here: thelancet.com/issue/S1470-20…View quoted post on X
The EU-funded MSCA Doctoral Network “Spatial Crosstalk in Immune-Oncology” (SpaXio) is now officially recruiting 14 PhD students to decipher the metastasis-promoting microenvironment of colon and breast cancer. More info here: tilsinbreastcancer.org/wp-content/upl…
Study across 45 institutions shows AI validity in TIL quantification for melanoma. Reproducible with prognostic validity and open-source. @tznaung 👉 jamanetwork.com/journals/jaman…
#AIinPathology #Melanoma #ComputationalPathology
#AIinPathology #Melanoma #ComputationalPathology
jamanetwork.com Pathologist-Read vs AI-Driven Assessments of Tumor-Infiltrating Lymphocytes This prognostic study compares the analytical and clinical validity of a machine learning algorithm with traditional pathologist-read methods for quantification of tumor-infiltrating lymphocytes in... 🎉 Thrilled to share that 2 @JPathol papers from the TILs Working Group ranked in the Top 10% most-viewed in 2023!
👏 Huge thanks to all collaborators, @JPathol & our readers for your support.
📎 Links in comments ⬇️
#TopViewedArticle #TILsinBreastCancer #pathology
👏 Huge thanks to all collaborators, @JPathol & our readers for your support.
📎 Links in comments ⬇️
#TopViewedArticle #TILsinBreastCancer #pathology